MARKET RADAR
SENSEX     NIFTY      
GlaxoSmithKline Pharmaceuticals Key Financial Ratios, GlaxoSmithKline Pharmaceuticals Financial Statement & Accounts
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Key Financial Ratios - GlaxoSmithKline Pharmaceuticals
GlaxoSmithKline Pharmaceuticals
BSE: 500660|NSE: GLAXO|ISIN: INE159A01016|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
  
LIVE
BSE
Feb 10, 15:46
2032.95
-9.25 (-0.45%)
VOLUME 1,275
LIVE
NSE
Feb 10, 15:40
2034.55
-4.7 (-0.23%)
VOLUME 13,930

Key Financial Ratios of GlaxoSmithKline Pharmaceuticals

Dec '10 Dec '09 Dec '08 Dec '07 Dec '06
Investment Valuation Ratios
Face Value 10.00 10.00 10.00 10.00 10.00
Dividend Per Share 40.00 30.00 40.00 36.00 31.00
Operating Profit Per Share (Rs) 91.01 81.28 71.83 66.58 58.59
Net Operating Profit Per Share (Rs) 250.90 222.44 197.91 186.37 182.04
Free Reserves Per Share (Rs) 217.45 197.18 171.44 150.16 130.54
Bonus in Equity Capital 48.03 48.03 48.03 48.03 48.03
Profitability Ratios
Operating Profit Margin(%) 36.27 36.54 36.29 35.72 32.18
Profit Before Interest And Tax Margin(%) 33.47 33.77 33.24 33.12 29.62
Gross Profit Margin(%) 35.44 35.67 35.32 38.62 35.48
Cash Profit Margin(%) 27.07 27.16 27.01 33.48 34.61
Adjusted Cash Margin(%) 27.07 27.16 27.01 25.79 23.46
Net Profit Margin(%) 25.05 25.74 32.36 32.50 33.63
Adjusted Net Profit Margin(%) 25.05 25.74 32.36 24.81 22.48
Return On Capital Employed(%) 45.35 44.09 45.06 45.60 46.67
Return On Net Worth(%) 29.19 29.12 37.41 39.51 45.66
Adjusted Return on Net Worth(%) 30.64 29.79 30.16 30.16 30.52
Return on Assets Excluding Revaluations 227.95 207.68 181.94 160.67 30.70
Return on Assets Including Revaluations 227.95 207.68 181.94 160.67 30.70
Return on Long Term Funds(%) 45.35 44.09 45.06 45.60 46.67
Liquidity And Solvency Ratios
Current Ratio 2.94 3.06 1.94 0.91 0.94
Quick Ratio 2.53 2.63 1.58 0.54 0.46
Debt Equity Ratio -- -- -- -- --
Long Term Debt Equity Ratio -- -- -- -- --
Debt Coverage Ratios
Interest Cover 1,412.90 2,126.03 1,326.05 978.15 880.22
Total Debt to Owners Fund 0.00 0.00 0.00 0.00 0.00
Financial Charges Coverage Ratio 1,441.27 2,170.75 1,357.13 472.16 426.97
Financial Charges Coverage Ratio Post Tax 936.34 1,445.42 1,129.05 409.93 417.04
Management Efficiency Ratios
Inventory Turnover Ratio 7.82 7.71 7.85 8.03 6.73
Debtors Turnover Ratio 42.18 33.74 35.03 32.15 24.12
Investments Turnover Ratio 7.82 7.71 7.85 8.51 7.09
Fixed Assets Turnover Ratio 6.67 6.52 5.94 16.85 17.70
Total Assets Turnover Ratio 1.10 1.07 1.08 1.16 1.28
Asset Turnover Ratio 6.67 6.52 5.94 5.92 6.08
Average Raw Material Holding 73.53 66.98 87.21 66.56 74.12
Average Finished Goods Held 47.59 50.76 45.50 50.01 59.67
Number of Days In Working Capital 280.85 278.86 149.15 -13.58 -7.85
Profit & Loss Account Ratios
Material Cost Composition 37.67 38.67 38.96 39.04 42.23
Imported Composition of Raw Materials Consumed 28.15 29.86 29.86 27.41 27.94
Selling Distribution Cost Composition 6.61 6.95 5.64 6.24 6.70
Expenses as Composition of Total Sales 5.08 6.48 5.74 5.30 3.84
Cash Flow Indicator Ratios
Dividend Payout Ratio Net Profit 69.54 57.43 68.75 66.35 54.88
Dividend Payout Ratio Cash Profit 67.43 55.65 66.85 64.41 53.33
Earning Retention Ratio 33.74 43.87 14.74 13.09 17.90
Cash Earning Retention Ratio 35.66 45.57 17.64 16.38 21.32
AdjustedCash Flow Times 0.01 0.01 0.01 0.01 0.01
Dec '10 Dec '09 Dec '08 Dec '07 Dec '06
Earnings Per Share 66.55 60.48 68.07 63.48 64.40
Book Value 227.95 207.68 181.94 160.67 141.05
Source : Dion Global Solutions Limited
Explore GlaxoSmithKline connections
Quick Links for glaxosmithklinepharmaceuticals
Follow moneycontrol.com

Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.